Article Information
History
- December 18, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Anders Hviid, MSc, DrMedSci1,9,*,
- Tuomo A. Nieminen, MSocSc2,
- Nicklas Pihlström, MSc3,
- Nina Gunnes, MSc, PhD4,5,
- Jesper Dahl, MD, PhD4,
- Øystein Karlstad, MScPharm, PhD4,
- Hanne Løvdal Gulseth, MD, PhD4,
- Anders Sundström, BA, PhD6,
- Anders Husby, MD, PhD1,
- Jørgen Vinsløv Hansen, MSc, PhD1,
- Rickard Ljung, MD, MPH, PhD6,8 and
- Petteri Hovi, MD, PhD7
- 1Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark
- 2Information Services, Finnish Institute for Health and Welfare, Helsinki, Finland
- 3Division of Licensing, Swedish Medical Products Agency, Uppsala, Sweden
- 4Norwegian Institute of Public Health, Oslo, Norway
- 5Norwegian Research Centre for Women’s Health, Oslo University Hospital, Oslo, Norway
- 6Division of Use and Information, Swedish Medical Products Agency, Uppsala, Sweden
- 7Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland
- 8Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
- 9Department of Drug Design and Pharmacology, Pharmacovigilance Research Center, University of Copenhagen, Copenhagen, Denmark
- ↵*Corresponding author: Anders Hviid MSc, DrMedSci; Department of Epidemiology Research, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark (aii{at}ssi.dk).